Assessing the Manufacturability and Critical Quality Attribute Profiles of Anti-IL-8 Immunoglobulin G Mutant Variants
Sign Up to like & getrecommendations! Published in 2024 at "Molecular Pharmaceutics"
DOI: 10.1021/acs.molpharmaceut.4c01010
Abstract: Early-phase manufacturability assessment of high-concentration therapeutic monoclonal antibodies (mAbs) involves screening of process-related risks impacting their translation into the clinic. Manufacturing a mAb at scale relies on cost-effective and robust approaches to derisk manufacturability parameters,… read more here.
Keywords: manufacturability critical; quality attribute; assessing manufacturability; manufacturability ... See more keywords